TY - JOUR
T1 - Importance of reporting segmental bowel preparation scores during colonoscopy in clinical practice
AU - Jain, Deepanshu
AU - Momeni, Mojdeh
AU - Krishnaiah, Mahesh
AU - Anand, Sury
AU - Singhal, Shashideep
N1 - Publisher Copyright:
© 2015 Baishideng Publishing Group Inc. All rights reserved.
PY - 2015/4/7
Y1 - 2015/4/7
N2 - AIM: To evaluate the impact of reporting bowel preparation using Boston Bowel Preparation Scale (BBPS) in clinical practice. METHODS: The study was a prospective observational cohort study which enrolled subjects reporting for screening colonoscopy. All subjects received a gallon of polyethylene glycol as bowel preparation regimen. After colonoscopy the endoscopists determined quality of bowel preparation using BBPS. Segmental scores were combined to calculate composite BBPS. Site and size of the polyps detected was recorded. Pathology reports were reviewed to determine advanced adenoma detection rates (AADR). Segmental AADR's were calculated and categorized based on the segmental BBPS to determine the differential impact of bowel prep on AADR. RESULTS: Three hundred and sixty subjects were enrolled in the study with a mean age of 59.2 years, 36.3% males and 63.8% females. Four subjects with incomplete colonoscopy due BBPS of 0 in any segment were excluded. Based on composite BBPS subjects were divided into 3 groups; Group-0 (poor bowel prep, BBPS 0-3) n = 26 (7.3%), Group-1 (Suboptimal bowel prep, BBPS 4-6) n = 121 (34%) and Group-2 (Adequate bowel prep, BBPS 7-9) n = 209 (58.7%). AADR showed a linear trend through Group-1 to 3; with an AADR of 3.8%, 14.8% and 16.7% respectively. Also seen was a linear increasing trend in segmental AADR with improvement in segmental BBPS. There was statistical significant difference between AADR among Group 0 and 2 (3.8% vs 16.7%, p < 0.05), Group 1 and 2 (14.8% vs 16.7%, p < 0.05) and Group 0 and 1 (3.8% vs 14.8%, p < 0.05). χ 2 method was used to compute p value for determining statistical significance. CONCLUSION: Segmental AADRs correlate with segmental BBPS. It is thus valuable to report segmental BBPS in colonoscopy reports in clinical practice.
AB - AIM: To evaluate the impact of reporting bowel preparation using Boston Bowel Preparation Scale (BBPS) in clinical practice. METHODS: The study was a prospective observational cohort study which enrolled subjects reporting for screening colonoscopy. All subjects received a gallon of polyethylene glycol as bowel preparation regimen. After colonoscopy the endoscopists determined quality of bowel preparation using BBPS. Segmental scores were combined to calculate composite BBPS. Site and size of the polyps detected was recorded. Pathology reports were reviewed to determine advanced adenoma detection rates (AADR). Segmental AADR's were calculated and categorized based on the segmental BBPS to determine the differential impact of bowel prep on AADR. RESULTS: Three hundred and sixty subjects were enrolled in the study with a mean age of 59.2 years, 36.3% males and 63.8% females. Four subjects with incomplete colonoscopy due BBPS of 0 in any segment were excluded. Based on composite BBPS subjects were divided into 3 groups; Group-0 (poor bowel prep, BBPS 0-3) n = 26 (7.3%), Group-1 (Suboptimal bowel prep, BBPS 4-6) n = 121 (34%) and Group-2 (Adequate bowel prep, BBPS 7-9) n = 209 (58.7%). AADR showed a linear trend through Group-1 to 3; with an AADR of 3.8%, 14.8% and 16.7% respectively. Also seen was a linear increasing trend in segmental AADR with improvement in segmental BBPS. There was statistical significant difference between AADR among Group 0 and 2 (3.8% vs 16.7%, p < 0.05), Group 1 and 2 (14.8% vs 16.7%, p < 0.05) and Group 0 and 1 (3.8% vs 14.8%, p < 0.05). χ 2 method was used to compute p value for determining statistical significance. CONCLUSION: Segmental AADRs correlate with segmental BBPS. It is thus valuable to report segmental BBPS in colonoscopy reports in clinical practice.
KW - Adenomas
KW - Boston bowel preparation score
KW - Colorectal cancer screening
KW - Polyps
UR - http://www.scopus.com/inward/record.url?scp=84926625289&partnerID=8YFLogxK
U2 - 10.3748/wjg.v21.i13.3994
DO - 10.3748/wjg.v21.i13.3994
M3 - Article
C2 - 25852286
AN - SCOPUS:84926625289
SN - 1007-9327
VL - 21
SP - 3994
EP - 3999
JO - World Journal of Gastroenterology
JF - World Journal of Gastroenterology
IS - 13
ER -